Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes
A primary goal in the development of an AIDS vaccine is the elicitation of broadly neutralizing antibodies (bNAbs) that protect against diverse HIV-1 strains. To this aim, germline-targeting immunogens have been developed to activate bNAb precursors and initiate the induction of bNAbs. While most preclinical germline-targeting HIV-1 vaccine candidates only include a single bNAb precursor epitope, an effective HIV-1 vaccine will likely require bNAbs that target multiple epitopes on Env. Here, we report a newly designed germline-targeting Env SOSIP trimer, named 3nv.2, that presents three bNAb epitopes on Env: the CD4bs, V3, and V2 epitopes. 3nv.2 forms a stable trimeric Env and binds to bNAb precursors from each of the desired epitopes. Immunization experiments in rhesus macaques and mice demonstrate 3nv.2 elicits the combined effects of its parent immunogens. Our results provide proof of concept for using a germline-targeting immunogen presenting three or more bNAb epitopes and a framework to develop improved next-generation HIV-1 vaccine candidates.
Authors
- Michel C. Nussenzweig (ORCID: https://orcid.org/0000-0003-0592-8564)
- Leesa M. Kakutani
- Harald Hartweger (ORCID: https://orcid.org/0000-0002-1118-1818)
- Edem Gavor (ORCID: https://orcid.org/0000-0001-7100-7849)
- Olivia K. Donau (ORCID: https://orcid.org/0000-0002-8184-7849)
- Kaito Nagashima (ORCID: https://orcid.org/0000-0002-7501-6651)
- Harry B. Gristick (ORCID: https://orcid.org/0000-0002-1957-2821)
- Priyanthi N.P. Gnanapragasam
- Yoshiaki Nishimura (ORCID: https://orcid.org/0000-0003-1347-2368)
- Malcolm A. Martin (ORCID: https://orcid.org/0000-0002-6845-9905)
- Pamela J. Björkman (ORCID: https://orcid.org/0000-0002-2277-3990)
- Nicholas Koranda (ORCID: https://orcid.org/0009-0005-4082-7170)
- Jennifer R. Keeffe (ORCID: https://orcid.org/0000-0002-5317-6398)
- Anthony P. West (ORCID: https://orcid.org/0000-0003-4213-5184)
- Luisa N. Segovia
Institutions
- California Institute of Technology (US)
- Howard Hughes Medical Institute (US)
- National Institute of Allergy and Infectious Diseases (US)
- Rockefeller University (US)
Publication Details
- Journal
- The Journal of Experimental Medicine
- Published
- 2025-07-11
- DOI
- https://doi.org/10.1084/jem.20250693
- Citations
- 3
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.11
Funders
- Bill and Melinda Gates Foundation
- California Institute of Technology
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases